Mehmet AGIN, Yusuf KAYAR

The prevalence of Helicobacter Pylori and related conditions in Van province and its region

Aim: The prevalence of Helicobacter Pylori (HP) is up to 90% in developing countries, whereas it is less than 40% in developedcountries. This study aims to determine the prevalence of HP in Van city and its region and to investigate the relationship betweenthe presence of HP and the clinical, endoscopic appearanceMaterial and Methods: A total of 367 cases that presented with the dyspeptic complaints to the Gastroenterology outpatient-clinicand underwent upper-gastrointestinal endoscopy and gastric biopsies between July/2017-March/2019 were included in the study.The patients included in the study were divided into three age-groups (1-5 years, 6-10 years, 11-18 years). The clinical complaints,endoscopic findings were recorded in all patients. The relationship between HP positivity and clinical complaints, the endoscopicappearance was analyzed.Results: The presence of HP was found in 234(63.8%) patients. However, the incidence of HP was 63.8% in all patients; it was found34.6% between 1-5 years, 61.8% between 6-10 years, and 71.2% between 11-18 years, respectively. The duodenal ulcer was found in8.5%(20/234) of HP positive cases, and 3.5%(5/133) of HP negative cases. In predicting the presence of HP, the ulcer specificity wasdetermined 96%, the sensitivity was 8.5%, the positive predictive value was 80%, and the negative predictive value was found 37.4%Conclusion: HP should be considered in patients with recurrent and chronic abdominal pain. Endoscopic appearance of nodularantral gastritis and the ulcer should suggest HP infection. The high rate of activity and chronicity in HP positive cases indicates theimportance of HP eradication therapy.

PDF

___

1. Tonkic A, Tonkic M, Lehours P, et al. Epidemiology and diagnosis of helicobacter pylori infection. Helicobacter 2012;17:1-8.
2. Laszewicz W, Iwanczak F, Iwanczak B. Task Force of the Polish Society of Gastroenterology; Task Force of the Polish Society of Gastroenterology. Seroprevalence of Helicobacter pylori infection in Polish children and adults depending on socioeconomic status and living conditions. Adv Med Sci 2014;59:147-50.
3. Erbey F, Acar MN, Okur M, et al. Van Gölü Havzasında 1-18 Yaş Grubu Çocuklarda Helicobacter pylori Sıklığı. Çocuk Enf Derg 2010;4:93-5.
4. Doğan Y, Barıs S, Erkan T, et al. Çocuklarda Helicobacter pylori enfeksiyonu: Yakınma, endoskopik bulgu, tanı yöntemleri ve tedavi sonrası eradikasyon oranlarının değerlendirilmesi. Turk Arch Ped 2007;42:98-102.
5. Doğancı T, Kansu A, Doğancı L, et al. 6 ay-5 yaş arası çocuklarda Helicobacter Pylori seroprevalansı. Turk J Gastroenterol 1998;2:138-45.
6. Price AB. The Sydney System: Histological division. J Gastroenterol Hepatol 1991;6:209-22.
7. Goral V,Ozdal B, Kaplan A, et al. Diyarbakır ilinde Helikobakter pilori antikor prevalansı. Akademik Gastroenteroloji Dergisi 2006;5:47-50.
8. Ceylan A, Kirimi E, Tuncer O, et al. Prevalence of Helicobacter pylori in children and their family members in a district in Turkey. J Health Popul Nutr 2007;25:422-7.
9. Ozden A, Bozdayi G, Ozkan M, et al. Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years. Turk J Gastroenterol 2004;15:156-8.
10. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
11. Erkan T, Kutlu T, Cullu F, et al. Peptik ülserli hastalarımızın retrospektif dökümü. Cerrahpaşa J Med 1998;29:84-8.
12. Trabzon M, Emiroğlu HH, Kösecik M, et al. Üst gastrointestinal kanama ve helikobakter pilori arasındaki bağlantı. Genel Tıp Derg 1988;55:55-8.
13. Soğut A, Acun C, Cavuldak S, et al. Zonguldak ilinde 6 ay-15 yaş grubu çocuklarda Helicobacter pylori seropozitifliği ve risk etmenlerinin incelenmesi. Türk Pediatri Arşivi 2004;39:152-7.
14. Ertem D, Harmanci H, Pehlivanoğlu E. Helicobacter pylori infection in Turkish preschool and school children: role of socioeconomic factors and breast feeding. Turk J Pediatr 2003;45:114-22.
15. Crone J, Gold BD. Helicobacter Pylori infection in pediatrics. Helicobacter 2004;9:49-56.
16. Porsch-Ozcurumez M, Doppl W, Hardt PD, et al. Impact of migration on Helicobacter pylori seroprevalence in the off spring of Turkish immigrants in Germany. Turk J Pediatr 2003;45:203-8.
17. Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter 2008;13:1-6.
18. Bode G, Brenner H, Adler G, et al. Recurrent abdominal pain in children:evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. J Psychosom Res 2003;54:417-21.
19. Macarthur C. Helicobacter pylori, non-ulcer dyspepsia, and childhood recurrent abdominal pain. Pediatr Res 2001;49:140.
20. Zeyrek D, Zeyrek F, Cakmak A, et al. Association of Helicobacter pylori and giardiasis in children with recurrent abdominal pain. Turkiye Parazitol Derg 2008;32:4-7.
21. Gulcan EM, Varol A, Kutlu T, et al. Helicobacter pylori stool antigen test. Indian J Pediatr 2005;72:675-8.
22. Ozturk H, Senocak ME, Uzunalimoglu B, et al. Helicobacter pylori infection in symptomatic and asymptomatic children: a prospective clinical study. Eur J Pediatr Surg 1996;6:265-9.
23. Us D, Hascelik G. Seroprevalence of Helicobacter pylori infection in an Asymptomatic Turkish population. J Infect 1998;37:148-50.
24. De Giacomo C, Valdambrini V, Lizzoli F, et al. Apopulation-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents. Helicobacter 2002;7:356-63.
25. Giesecke J. International association between Helicobacter pylori and gastric cancer. Lancet 1993;342:120-1.
26. Salih BA, Abasiyanik MF, Bayyurt N, et al. H pylori infection and other risk factors associated with peptic ulcers in Turkish patients: a retrospective study. World J Gastroenterol 2007;13:3245-8.
27. Ozcay F, Kocak N, Temizel IN, et al. Helicobacter Pyloriinfection in Turkish children: Comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication. Helicobacter 2004;9:242–8.